Munchausen syndrome by genetics: Next-generation challenges for clinicians.
From the Institute of Neurogenetics (S.Z., K.L., C.K., A.M.), University of Lübeck; and the Institute of Medical Genetics and Applied Genomics (P.B.), University Hospital of Tübingen, Germany.
Simone
S
Zittel
From the Institute of Neurogenetics (S.Z., K.L., C.K., A.M.), University of Lübeck; and the Institute of Medical Genetics and Applied Genomics (P.B.), University Hospital of Tübingen, Germany.
Katja
K
Lohmann
From the Institute of Neurogenetics (S.Z., K.L., C.K., A.M.), University of Lübeck; and the Institute of Medical Genetics and Applied Genomics (P.B.), University Hospital of Tübingen, Germany.
Peter
P
Bauer
From the Institute of Neurogenetics (S.Z., K.L., C.K., A.M.), University of Lübeck; and the Institute of Medical Genetics and Applied Genomics (P.B.), University Hospital of Tübingen, Germany.
Christine
C
Klein
From the Institute of Neurogenetics (S.Z., K.L., C.K., A.M.), University of Lübeck; and the Institute of Medical Genetics and Applied Genomics (P.B.), University Hospital of Tübingen, Germany. alexander.muenchau@neuro.uni-luebeck.de.
Alexander
A
Münchau
D000328:Adult; D005260:Female; D006136:GTP Cyclohydrolase / Q000235:genetics*; D006801:Humans; D009110:Munchausen Syndrome / Q000235:genetics* / Q000503:physiopathology; D009154:Mutation / Q000235:genetics*; D014446:Tyrosine 3-Monooxygenase / Q000235:genetics*
D014446:Tyrosine 3-Monooxygenase; D006136:GTP Cyclohydrolase